A Study to Evaluate the Safety of Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product StromaForte for the Treatment of Knee Osteoarthritis
Clinical trial NCT06084988 · COMPLETED
Trial details
- NCT number
- NCT06084988
- Sponsor
- Cellcolabs Clinical SPV Limited
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-07
- Primary completion
- 2024-10-29
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.